BEAM - Beam Therapeutics Inc.
25.52
-1.920 -7.524%
Share volume: 2,087,868
Last Updated: 03-05-2026
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
-0.04%
PREVIOUS CLOSE
CHG
CHG%
$27.44
-1.92
-0.07%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 05-07-2024 | 08-06-2024 | 11-05-2024 | 02-25-2025 | 05-06-2025 | 11-04-2025 | 02-24-2026 | |
| Cash flow financing | 2.897 M | 133.000 K | 1.262 M | 3.444 M | 473.379 M | 1.675 M | 1.886 M | |
| Other financing cash flows | 1.676 M | 240.000 K | 239.000 K | 3.445 M | 719.000 K | 412.000 K | 1.886 M | |
| Cash flow | -150.314 M | 4.617 M | -62.165 M | 53.359 M | 244.406 M | -14.149 M | 27.004 M | |
| Net income | -98.669 M | -91.051 M | -96.668 M | -90.354 M | -109.270 M | -112.728 M | 244.297 M | |
| Depreciation | 5.431 M | 5.576 M | 5.475 M | 5.443 M | 5.528 M | 5.560 M | 5.668 M | |
| Changes in inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Changes in receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Cashflow | -53.464 M | 87.493 M | 24.698 M | 126.280 M | -125.089 M | 65.655 M | 108.407 M | |
| Net Borrowings | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Activity Other | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Dividends Paid | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Exchange Rate Effect | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Capital Expenditures | 2.438 M | 1.961 M | 1.577 M | 2.970 M | 3.065 M | 5.011 M | 3.734 M | |
| Cash Change | -150.314 M | 4.617 M | -62.165 M | 53.359 M | 244.406 M | -14.149 M | 27.004 M |